Key Record Dates
ClinicalTrials.gov Identifier: | NCT04343885 |
---|---|
Brief Title: | In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy (UpFrontPSMA) |
First Submitted : | April 1, 2020 |
First Submitted that Met QC Criteria : | April 9, 2020 |
First Posted : | April 13, 2020 |
Last Update Submitted that Met QC Criteria : | November 4, 2022 |
Last Update Posted : | November 7, 2022 |